Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2018
View Archived Issues
Novo Nordisk licenses EPGN-696 from Epigen
Read More
CEPI and IAVI partner to develop Lassa fever vaccine
Read More
Recombinant human pentraxin 2 slows decline in lung function in IPF patients
Read More
Updated results strengthen previously reported 2-year survival rate of TG-01
Read More
Recro receives complete response letter from the FDA for intravenous meloxicam
Read More
Celon Pharma evaluates 5-HT6 receptor antagonist PZ-KKN-94 in vitro and in vivo
Read More
Portola Pharmaceuticals receives milestone payment following Andexxa approval
Read More
Phase III iLLUMINATE trial of Imbruvica plus Gazyva in first-line CLL/SLL meets primary endpoint
Read More
PACIFIC trial of Imfinzi in NSCLC meets second primary endpoint of overall survival
Read More
Alliance between Bicycle Therapeutics and ThromboGenics sees milestone and expansion
Read More
FDA grants fast track designation for KB-103
Read More
New prostate cancer model generated through Pmepa1 gene knockout
Read More
FDA approves Palynziq for adults with phenylketonuria
Read More
First patient dosed in first-in-human trial of MCLA-158 in solid tumors
Read More
Preliminary results from phase I pivotal study of Tonmya
Read More
Chugai seeks Japanese approval for Actemra for adult-onset Still's disease
Read More
New NTRK1 inhibitors discovered at Shionogi
Read More
Phase III study of Arzerra plus bendamustine in indolent NHL did not meet primary endpoint
Read More
FDA accepts NDA resubmission for Dsuvia
Read More
Takeda describes metabotropic glutamate mGlu7 receptor agonists
Read More
Vanderbilt University discovers muscarinic acetylcholine M4 receptor positive allosteric modulators
Read More
CLCF1 biomarker may help diagnose delayed graft function in kidney transplantation
Read More
European designation decisions for BioCryst's BCX-7353 for HAE
Read More
Sichuan Kelun-Biotech Biopharmaceutical presents antiviral compounds
Read More
Ficolin binding inhibitors patented by Osaka University
Read More
License agreement and collaborations support development of human Nipah virus vaccine
Read More
Voyager Therapeutics develops AAV gene therapy for Friedreich's ataxia
Read More
Researchers create a renal medullary carcinoma mouse model for chemotherapy testing
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe